Introduction
Controlled medicines and prescription compliance in Turkish pharmacy law are among the most sensitive areas of healthcare regulation in Turkey. Pharmacies are not ordinary commercial stores, and controlled medicines are not ordinary healthcare products. These medicines may have abuse potential, dependency risk, psychiatric or neurological effects, diversion risk, public health consequences and criminal law implications. For this reason, Turkish law regulates their prescription, dispensing, storage, recording and inspection with strict rules.
The main legal framework is based on Law No. 6197 on Pharmacists and Pharmacies, the Regulation on Pharmacists and Pharmacies, TİTCK systems, electronic prescription rules, the medicine tracking system and, where relevant, criminal law provisions concerning narcotic and psychotropic substances. Law No. 6197 defines pharmacy as a healthcare service involving medicine preparation, supply, safety monitoring, quality assurance, patient information and reporting of medicine-related problems; it also states that opening and operating a pharmacy requires being a pharmacist.
Controlled medicine compliance is therefore not merely a technical pharmacy procedure. It is a legal risk management obligation. A pharmacy that unlawfully supplies controlled medicines, accepts invalid prescriptions, fails to preserve prescription records, ignores electronic prescription rules, makes incorrect İTS entries or cannot explain stock discrepancies may face administrative sanctions, professional disciplinary proceedings, SGK reimbursement disputes, civil liability and, in serious cases, criminal investigation.
Legal Meaning of Controlled Medicines in Turkish Pharmacy Practice
The expression “controlled medicines” is commonly used to refer to medicines whose prescription, supply, recording or monitoring is subject to stricter rules than ordinary medicines. These may include narcotic medicines, psychotropic medicines, medicines subject to red or green prescription rules, and other medicines that must be monitored through special prescription or electronic systems.
The Regulation on Pharmacists and Pharmacies specifically regulates narcotic and psychotropic medicine prescriptions. It provides that narcotic and psychotropic medicines may be dispensed only when written on special prescriptions, except for electronic prescriptions signed with electronic signature. It also states that such prescriptions are not returned to the patient and that a new prescription is required for repeat supply.
This special treatment reflects the high-risk character of these products. Ordinary prescription compliance is already important, but controlled medicines require an additional layer of caution. The pharmacist must verify the prescription type, prescriber authority, electronic system status, patient identity where relevant, medicine quantity, repeat rules, prescription preservation and stock consistency.
Red, Green and Other Special Prescription Categories
In Turkish practice, controlled medicines are often associated with red prescriptions and green prescriptions. Red prescriptions are generally connected with narcotic medicines, while green prescriptions are generally connected with psychotropic medicines. Other controlled categories may involve special prescription or monitoring rules depending on the product and regulatory classification.
The historical paper-based colored prescription system has largely moved toward electronic systems. The Renkli Reçete System was introduced to transfer colored prescriptions, including red and green prescriptions, into electronic form. Professional chamber announcements from 2017 explain that, from 17 March 2017, red and green prescriptions were to be processed electronically nationwide, subject to limited exceptions.
For pharmacies, the key legal point is that controlled medicine prescriptions cannot be treated like ordinary informal medicine requests. A patient’s statement, old prescription box, screenshot, phone message, foreign medicine history or verbal explanation is not enough. The medicine must be supplied only through the legally accepted prescription route.
Electronic Colored Prescription System
The electronic colored prescription system is central to modern controlled medicine compliance. It reduces paper-based misuse, improves traceability, supports monitoring of controlled medicines and allows prescriptions to be processed in a more secure digital environment.
Professional guidance on the Renkli Reçete System explains that red and green prescriptions issued electronically do not require a separate paper red or green prescription, while certain exceptional situations may still involve paper prescriptions. These exceptions historically included technical system failure, non-integrated health service providers, personalized foreign-sourced narcotic or psychotropic medicines, veterinary prescriptions and certain magistral prescriptions involving controlled substances.
The practical consequence is clear: pharmacists must distinguish between a valid electronic colored prescription and an invalid or incomplete request. If the electronic system is available, controlled medicine supply should be processed through the system. If a paper prescription is presented under an exception, the pharmacist must verify that the exception is legally valid and that required statements, signatures or supporting documents exist.
Prescription Compliance as a Pharmacist’s Professional Duty
Prescription compliance is one of the core duties of the pharmacist. Law No. 6197 states that medicines legally required to be supplied against prescription cannot be supplied without prescription. It also prohibits wholesale sale of poisonous and potent substances and medicines from pharmacies.
The pharmacist is not a passive seller. The pharmacist must examine whether a prescription can legally be accepted, whether the medicine can be dispensed, whether the quantity is permitted, whether the prescription is suspicious and whether special rules apply. This is especially important for controlled medicines because unlawful supply may create not only administrative liability but also criminal risk.
Where a prescription appears incorrect, suspicious, excessive or inconsistent, the pharmacist should not simply dispense the medicine. The pharmacist must follow the applicable legal and professional route, including physician confirmation where required, refusal of unlawful supply, documentation of the issue and preservation of relevant records.
Requirements for Valid Controlled Medicine Prescriptions
A controlled medicine prescription must satisfy both general prescription requirements and special controlled medicine requirements. The Regulation on Pharmacists and Pharmacies requires prescriptions to include information such as patient identity, diagnosis, physician identity, title, diploma registration number, place of duty and signature. It also recognizes normal prescriptions, special prescriptions for monitored medicines, electronic prescriptions and restricted prescriptions requiring additional security measures.
For controlled medicines, the pharmacist must additionally check whether the medicine is subject to a special prescription category. Narcotic and psychotropic medicines generally require special prescription rules unless a legally valid electronic prescription exists. The Regulation also provides that narcotic and psychotropic prescriptions are not returned to the patient and that one copy is preserved at the pharmacy according to institutional procedures.
This means that the pharmacist’s compliance review should not end with seeing a prescription. The pharmacist must ask: Is this the correct prescription type? Is the prescription electronic where required? Is the prescriber authorized? Is the quantity lawful? Is the prescription current? Does the system confirm it? Does the pharmacy need to preserve a copy? Does the medicine require additional recording?
Repeat Supply and New Prescription Requirement
Controlled medicines cannot usually be supplied repeatedly on the basis of the same prescription unless the legal framework expressly allows it. The Regulation states that narcotic and psychotropic medicine prescriptions are not returned to the patient and that a new prescription must be presented for repeated supply.
This rule is important because patients may request repeat supply by arguing that they are already using the medicine, that their doctor previously prescribed it, that they lost the medicine, that they are traveling or that an appointment is delayed. These circumstances may create practical hardship, but they do not remove the pharmacist’s legal obligation.
A pharmacy should not create informal exceptions for controlled medicines. If the law requires a new prescription, the pharmacist should guide the patient to the prescribing physician or appropriate healthcare provider rather than supplying the medicine unlawfully.
Record-Keeping Duties for Controlled Medicines
Record-keeping is one of the strongest compliance requirements in controlled medicine practice. The Regulation provides that prescriptions for narcotic and psychotropic medicines are not returned to the patient; a copy is kept at the pharmacy and procedures are carried out according to institutional rules. It also states that certain controlled medicines supplied under normal prescription but subject to monitoring must have prescription records kept electronically, recorded in the medicine tracking system and preserved at the pharmacy.
These records are not optional. They may become decisive evidence in pharmacy inspections, SGK audits, patient disputes, criminal investigations, stock discrepancies or professional disciplinary proceedings. A pharmacy that cannot produce proper records may face serious difficulty even if the pharmacist believes that the medicine was supplied lawfully.
The responsible pharmacist should therefore ensure that controlled medicine records are accurate, complete, secure and easily retrievable. Staff should be trained that controlled medicine records cannot be treated casually or corrected informally without a documented lawful basis.
İTS and Controlled Medicine Traceability
The İlaç Takip Sistemi, known as İTS, is another key element of controlled medicine compliance. Law No. 6197 provides that medicine sales, returns to warehouses, returns to other warehouses in force majeure situations, pharmacy-to-pharmacy exchanges and destruction of expired or deteriorated medicines must be notified through the medicine tracking system. The law also prohibits internet or electronic sale of medicines and restricts prescription referral and collection practices.
For controlled medicines, İTS consistency is especially important. Physical stock, electronic stock, purchase invoices, prescription records, sale notifications and return or destruction documents should all match. A discrepancy involving an ordinary medicine may already create inspection risk; a discrepancy involving narcotic or psychotropic medicines can raise much more serious questions.
Pharmacies should perform frequent internal reconciliation for controlled medicines. The pharmacist should personally review high-risk stock differences. Any unexplained shortage, excess, damaged package, incorrect entry or return problem should be documented and resolved through lawful procedures.
Storage and Security of Controlled Medicines
Controlled medicines require careful storage because of diversion, misuse and inspection risks. Although storage standards may vary depending on the medicine category, the general duty of the pharmacist is to preserve medicines properly, prevent unauthorized access and ensure that only authorized persons handle high-risk products.
Law No. 6197 states that poisonous and potent medicines must be preserved and supplied according to the relevant laws and regulations. This principle is especially relevant to controlled medicines. The pharmacist should ensure secure storage, limited staff access, regular inventory checks and clear responsibility for stock handling.
Poor storage practices can lead to multiple problems. A missing package may suggest diversion. A damaged or expired controlled medicine may create patient safety risk. An unrecorded stock movement may trigger inspection findings. A medicine stored in a way that compromises quality may expose the pharmacy to civil and administrative liability.
Prescription Collection and Referral Prohibition
Controlled medicine compliance is also connected to the prohibition on prescription collection and referral schemes. Law No. 6197 provides that pharmacists may not cooperate openly or secretly with institutions, physicians, healthcare organizations or third parties for prescription referral; they may not keep brokers, courier personnel or similar directing staff; and they may not collect, direct or accept prescriptions obtained through such methods. The 2025 consolidated text also reflects the prohibition in its current form.
This rule is particularly important for controlled medicines because prescription steering may create abuse, illegal supply or SGK fraud risks. A pharmacy should be careful with clinics, private hospitals, psychiatric practices, nursing homes, medical tourism agencies, couriers, call centers or online platforms. Any arrangement that channels controlled medicine prescriptions to a particular pharmacy may be scrutinized.
The safest practice is to keep the pharmacy’s relationship with patients and prescribers transparent, professional and free from financial or hidden referral arrangements.
Online Sales and Digital Requests
Medicines cannot be sold through the internet or other electronic environments in Turkey, and pharmacy pharmacists or pharmacies cannot open websites in their names under Law No. 6197. This rule has particular importance for controlled medicines.
A controlled medicine request sent through WhatsApp, Instagram, website form, marketplace message, courier platform or informal online channel cannot be treated as a lawful prescription route. Even where the patient claims urgency, prior use or physician advice, the pharmacist should not supply controlled medicines through unlawful digital ordering systems.
Digital evidence can also be risky. Screenshots, chat records, payment messages, courier notes and online advertisements may be used in inspections or investigations. Pharmacies should therefore adopt a strict internal policy: no online sale, no social media order, no courier-based controlled medicine supply outside lawful prescription and delivery rules.
SGK Reimbursement and Controlled Medicines
Controlled medicines may also create SGK reimbursement risks. A prescription may be medically necessary and legally valid, but SGK reimbursement may still require compliance with SUT rules, report conditions, diagnosis codes, physician specialty requirements, quantity limits or system entries.
For controlled medicines, reimbursement review should be stricter because errors may trigger both payment deductions and broader scrutiny. A pharmacy should check whether the prescription is valid, whether the medicine is reimbursable, whether the patient eligibility is correct, whether the report is valid, whether the electronic system accepts the prescription and whether supporting documents are preserved.
A MEDULA or system approval should not be treated as the only compliance control. SGK may later audit the prescription and apply deductions if reimbursement conditions were not actually satisfied at the time of dispensing.
Criminal Law Risks
Controlled medicines may have criminal law implications where they fall within the scope of narcotic or psychotropic substance rules or where unlawful supply amounts to unauthorized sale, transfer, storage or provision of regulated substances. Turkish Penal Code Article 188 criminalizes unauthorized or unlawful manufacture, import, export, sale, offering for sale, giving to others, transport, storage, purchase, acceptance or possession of narcotic or psychotropic substances in certain circumstances.
TCK Article 191 separately regulates purchasing, accepting, possessing or using narcotic or psychotropic substances for personal use, with a penalty framework and procedural consequences.
A pharmacy-related case will depend heavily on the facts, the medicine, the prescription status, quantity, records, intent, patient identity, supply route and whether the product is lawfully prescribed. The pharmacist’s role can be very different from an ordinary drug offense; however, unlawful dispensing, forged prescriptions, diversion, sale outside prescription rules or stock manipulation may trigger serious criminal investigation.
Forged Prescriptions and Suspicious Transactions
Forged prescriptions are among the highest-risk areas in controlled medicine compliance. A pharmacy should be alert to suspicious prescription patterns, such as unusual quantities, repeated urgent requests, inconsistent patient information, prescription details not matching system records, prescriber irregularities, altered paper prescriptions, suspicious diagnosis patterns or repeated requests from intermediaries.
The pharmacist is expected to act with professional care. If a prescription appears suspicious, the pharmacist should not dispense the medicine until the issue is clarified through lawful channels. Where appropriate, the pharmacy should preserve documents, record the reason for refusal, contact the prescriber through reliable channels or notify the relevant authority according to applicable procedures.
Failure to detect a sophisticated forgery may not always create liability if the pharmacist acted reasonably. However, ignoring obvious signs of forgery, repeatedly processing suspicious prescriptions or participating in false prescription activity may create civil, administrative, disciplinary and criminal liability.
Patient Counseling and Controlled Medicines
Controlled medicines often require careful patient counseling. The pharmacist should explain lawful and safe use, dosage instructions, storage conditions, warnings, interaction risks, dependency concerns where relevant, and the importance of following physician instructions.
This counseling must remain within professional boundaries. The pharmacist should not independently change dosage, encourage misuse, recommend controlled medicines without prescription or give advice that replaces physician supervision. The pharmacist’s duty is to support safe use of a lawfully prescribed medicine, not to create demand or facilitate unauthorized use.
Proper counseling also protects the pharmacist. If a patient later claims that they were not warned, pharmacy records, prescription documents and documented counseling practices may support the pharmacy’s position.
Inspection Risks for Pharmacies
Pharmacies are subject to inspection. The Regulation on Pharmacists and Pharmacies provides that pharmacy inspections are carried out by TİTCK health inspectors or pharmacists assigned by provincial health directorates, and that pharmacies are inspected at least twice per year and whenever necessary.
Controlled medicines are likely to be reviewed carefully during inspections. Inspectors may examine prescription records, special prescription copies, electronic colored prescription system entries, İTS data, physical stock, expired products, storage practices, staff access and any suspicious transaction history.
If deficiencies are detected, the pharmacy may be given time to correct some issues depending on the nature of the deficiency. However, serious problems involving controlled medicines may lead to stronger measures, including administrative sanctions, professional disciplinary referral or criminal notification.
Administrative Sanctions and Professional Liability
Administrative consequences may arise from invalid prescription processing, missing controlled medicine records, stock discrepancies, improper storage, unlawful online sales, prescription steering, failure to use İTS properly or failure to cooperate during inspections. Professional disciplinary liability may also arise because such conduct affects public trust in pharmacists and pharmacy services.
The pharmacist should remember that the responsible pharmacist is accountable for the pharmacy’s operation. Even if an employee made the immediate mistake, the pharmacist may still face liability if the mistake resulted from poor supervision, lack of procedures, inadequate training or systemic compliance failure.
A pharmacy handling controlled medicines should therefore have written internal procedures, staff training records, restricted access rules and regular pharmacist-led audits.
Civil Liability and Patient Harm
Civil liability may arise if a patient is harmed because of unlawful or negligent controlled medicine supply. Examples include wrong medicine, wrong dosage, supply without proper prescription, failure to detect an obvious prescription error, failure to provide necessary warnings, dispensing an expired or improperly stored medicine, or supplying a controlled medicine to the wrong person.
In such cases, the patient may claim compensation for treatment expenses, additional medical costs, loss of income, disability-related damages and moral damages depending on the circumstances. The pharmacy’s records will be crucial. If the prescription, electronic entry, İTS notification, counseling record and stock data are consistent, the pharmacist’s defense becomes stronger.
Compliance Checklist for Controlled Medicines
A pharmacy should apply a separate checklist for controlled medicines:
First, identify whether the medicine is subject to red, green or another special prescription category. Second, verify the prescription type and electronic system validity. Third, check prescriber authority and prescription completeness. Fourth, confirm patient and prescription information through lawful systems where applicable. Fifth, verify quantity and repeat supply rules. Sixth, preserve special prescription copies or electronic records as required. Seventh, record the transaction in İTS and internal pharmacy systems accurately.
Eighth, reconcile physical stock with electronic records regularly. Ninth, restrict staff access to controlled stock. Tenth, refuse prescriptions obtained through unlawful referral, courier or intermediary systems. Eleventh, reject online or social media medicine requests. Twelfth, document suspicious prescription decisions. Thirteenth, train all pharmacy personnel on controlled medicine handling. Fourteenth, review SGK reimbursement conditions separately. Fifteenth, prepare for inspections with complete and accessible records.
Practical Examples of Non-Compliance
A pharmacy may face serious risk if it supplies a green prescription medicine based only on a patient’s old box, dispenses a controlled medicine after receiving a prescription photo by WhatsApp, accepts a paper red prescription without checking whether the electronic system should have been used, gives a controlled medicine repeatedly without a new prescription, records a sale in İTS but cannot produce the prescription, or has physical stock that does not match electronic records.
Other risky examples include allowing non-pharmacist staff to handle controlled medicines without supervision, accepting prescriptions collected by a clinic courier, supplying controlled medicines through online orders, failing to preserve special prescription copies, or processing prescriptions that appear obviously forged or altered.
These examples show why controlled medicine compliance must be proactive. Waiting until an inspection or complaint arises is too late.
Frequently Asked Questions
What are controlled medicines in Turkish pharmacy law?
Controlled medicines generally refer to medicines subject to stricter prescription, monitoring, recording or dispensing rules, including narcotic and psychotropic medicines and medicines requiring red, green or special prescription procedures.
Can narcotic and psychotropic medicines be dispensed without special prescription?
No. The Regulation on Pharmacists and Pharmacies provides that narcotic and psychotropic medicines may be dispensed only when written on special prescriptions, except for electronic prescriptions signed with electronic signature.
Are red and green prescriptions electronic in Turkey?
Yes, the colored prescription system has been transferred to electronic form for red and green prescriptions, subject to limited exceptions such as system failure, non-integrated providers and certain special prescription situations.
Can controlled medicines be sold online?
No. Law No. 6197 prohibits the sale of medicines through the internet or any other electronic environment and prohibits websites being opened in the name of pharmacy pharmacists or pharmacies.
What happens if a pharmacy has controlled medicine stock discrepancies?
Stock discrepancies may lead to inspection findings, administrative sanctions, professional disciplinary proceedings, SGK problems or criminal investigation depending on the medicine, quantity, records and circumstances.
Conclusion
Controlled medicines and prescription compliance in Turkish pharmacy law require the highest level of professional care. These medicines are legally sensitive because they may involve narcotic or psychotropic effects, dependency risk, misuse potential, public health concerns, electronic monitoring and criminal law consequences.
The basic principles are clear. Controlled medicines must be supplied only through legally valid prescriptions. Narcotic and psychotropic prescriptions are subject to special rules, and electronic colored prescription systems play a central role in modern practice. Controlled medicine prescriptions must not be returned to patients where the regulation requires preservation, and repeat supply generally requires a new prescription. Pharmacy records, İTS entries, physical stock and prescription documents must be consistent.
For pharmacists, the safest approach is strict preventive compliance. Every controlled medicine transaction should be verified, recorded, preserved and auditable. Staff should be trained, stock should be reconciled, suspicious prescriptions should be refused or clarified, online requests should be rejected and unlawful prescription referral systems should be avoided.
For patients, these rules protect safe access to high-risk medicines. For pharmacists, they protect professional reputation and reduce liability. For regulators, they support public health and prevent diversion. In Turkish pharmacy law, controlled medicine compliance is not a paperwork burden; it is a core legal duty of the pharmacy profession.
Yanıt yok